1 - 3 June, 2027
Congress CenterBasel SwitzerlandDr. Monika Semmrich, PhDPrincipal Scientist, Preclinical Research at BioInvent International ABSpeaker
Profile
Monika is an immunologist with a PhD from the Technical University in Munich. After receiving her PhD, she went on to a postdoc at the Immunology Department in Lund (Sweden), focusing on the characterization of intestinal cell subsets. In 2012, Monika joined BioInvent International AB, a company developing antibodies for the treatment of cancer using BioInvent’s F.I.R.S.T platform. Currently, she holds a position as Principal Scientist where she applies her immunological expertise to support and manage several preclinical projects, from the early discovery phase through to clinical stage.
Agenda Sessions
A Function-First Approach to Identify Regulatory T Cell-Targeting Antibodies for Immunotherapy
, 08:50View Session